About Probable E3 ubiquitin-protein ligase TRIML2
Probable E3 ubiquitin-protein ligase TRIML2 (TRIML2) is a protein
from Homo sapiens identified by UniProt accession
Q8N7C3, 437 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Probable E3 ubiquitin-protein ligase TRIML2 |
| UniProt accession | Q8N7C3 |
| Gene | TRIML2 |
| Organism | Homo sapiens |
| Length | 437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.30
- metabolite measurement · score 0.29
- unipolar depression · score 0.19
- response to selective serotonin reuptake inhibitor · score 0.19
- adolescent idiopathic scoliosis · score 0.16
- xanthine measurement · score 0.15
- pathological myopia · score 0.14
- neurofibrillary tangles measurement · score 0.11
- breast milk measurement · score 0.11
- age at menopause · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8N7C3-F1 | alphafold | PREDICTED | 85.98 | — |
Amino-acid sequence (437 residues)
MSKRLSPQLQ HNITEDAYCE THLEPTRLFC DVDQITLCSK CFQSQEHKHH MVCGIQEAAE NYRKLFQEIL NTSREKLEAA KSILTDEQER MAMIQEEEQN FKKMIESEYS MRLRLLNEEC EQNLQRQQEC ISDLNLRETL LNQAIKLATE LEEMFQEMLQ RLGRVGRENM EKLKESEARA SEQVRSLLKL IVELEKKCGE GTLALLKNAK YSLERSKSLL LEHLEPAHIT DLSLCHIRGL SSMFRVLQRH LTLDPETAHP CLALSEDLRT MRLRHGQQDG AGNPERLDFS AMVLAAESFT SGRHYWEVDV EKATRWQVGI YHGSADAKGS TARASGEKVL LTGSVMGTEW TLWVFPPLKR LFLEKKLDTV GVFLDCEHGQ ISFYNVTEMS LIYNFSHCAF QGALRPVFSL CIPNGDTSPD SLTILQHGPS CDATVSP
Explore Probable E3 ubiquitin-protein ligase TRIML2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets